Lung Disease


To lead the development of novel treatments to transform the lives of children and adults around the world who suffer from diseases such as cystic fibrosis and asthma.

Based at the Centre for Infection and Immunity, our leading researchers and scientists are developing major programmes to find solutions to the problems of difficult asthma, cystic fibrosis, lung infection and acute lung injury.

Our international team has also undertaken one of the most ambitious studies ever into the causes and treatment of cystic fibrosis. Led by Professor Stuart Elborn, this project has developed a groundbreaking treatment for those suffering from the Celtic gene mutation, proving that treating the underlying cause of cystic fibrosis may have profound effects on the disease.

Our determination is demonstrated by the recent appointment as Chair of Microbiology and Infectious Diseases of internationally-renowned researcher Professor Miguel Valvano, whose team will explore infections that cause major health risks for children and young adults suffering from conditions such as cystic fibrosis. The Centre focuses on a number of other disease areas which affect children - asthma, childhood arthritis, and infectious diseases such as pseudomonas and bronchiolitis. Recently our scientists at the Royal Belfast Hospital for Sick Children developed a test for meningitis that can produce results within an hour. Its speed is potentially life-saving in the treatment of young people with meningococcal meningitis and septicaemia who can become seriously ill very quickly.

Help us to develop new treatments that will provide patients with the best possible chance of leading full and productive lives.

“For people like me who live
with a chronic life-threatening
disease, having access to new
treatments from clinical trials
which improve my quality
of life has allowed me to
complete my medical studies”

Theresa White (23) Student of the Year 2011
and final year medical student who has had
cystic fibrosis since birth.